Conn is an Analyst at PharmaVentures. Prior to joining PharmaVentures, Conn worked as a Business Development Adviser for the University College Dublin spin-out, Phision Therapeutics. Here, he created a comprehensive business plan for the development of a small molecule candidate with a novel mechanism of action in the treatment of age-related macular degeneration. He also worked as the Head of Content Development at the education technology company, LearnSignal.
Before embarking on his professional career, Conn completed a Master of Biotechnology and Business (First Class Honours) from the UCD Michael Smurfit Graduate Business School. He also holds a BSc in Environmental Biology (First Class Honours) from University College Dublin.